1887
Volume 2021, Issue 2
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Background: Ventilator-associated pneumonia (VAP) is an infectious pulmonary disease that develops after 48 hours of ventilation. To date, several methods have been proposed to reduce VAP occurrence, such as the VAP prevention bundle, which involves raising the head of the bed, reducing sedation, avoiding deep vein thrombosis, and preventing peptic ulcer in the gastrointestinal system. The purpose of this study was to evaluate the role of personnel in hand washing, case airway suctioning, and systematic monitoring in the prevention of VAP.

Methods: In the current clinical trial, 129 patients hospitalized and intubated at Vali-e-Asr Hospital ICU in Arak, Iran, were included in the study and randomized to one of the three VAP prevention methods: group A, VAP prevention bundle measures; group B, group A measures plus washing of patients’ mouth with 0.12% chlorhexidine and suction of secretion every six hours; and finally group C, group B measures plus 72-hour suction package. Demographic information, VAP diagnosis, and outcome of each patient were recorded in the special checklist.

Results: The age of the patients ranged from 18 years to 93 years with a mean of 54.6 ± 21.8 years. There was no significant difference in age, sex, Clinical Pulmonary Infection Score (CPIS), and Glasgow Coma Scale (GCS) between the three groups. However, there is a significant relationship between chest X-ray (CXR) index and pneumonia in the three groups ( < 0.05). The prevalence of pneumonia is generally seen to be higher in patients who were local, diffuse, or patchy than those who had no infiltration ( < 0.05).

Conclusion: This study showed that the application of VAP prevention bundle measures, mouthwash with chlorhexidine, personnel hand washing, airway suctioning, and systematic monitoring is an efficient approach to the prevention of VAP in ICUs.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2021.21
2021-08-23
2021-09-20
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2021/2/qmj.2021.21.html?itemId=/content/journals/10.5339/qmj.2021.21&mimeType=html&fmt=ahah

References

  1. Kalanuria AA, Zai W, Mirski M. Ventilator-associated pneumonia in the ICU.Crit Care. 2014; 18:(2):208.
    [Google Scholar]
  2. Nazer MR, Darvishi M, Fouladvand HR. The pattern of antibiotic resistance of Streptococcus pneumoniae isolated from sputum of patients with respiratory infection. J Adv Pharm Edu Res. 2019; 9:(S2):121-8.
    [Google Scholar]
  3. Gunay L, Yesılbag Z, GedıkH, Karabela S¸N, Engin G, Gunaydın N, et al. Ventilator associated pneumonia prevention experience in cardiovascular surgical intensive care. Am J Card. 2018; 121:(8):e157-e8.
    [Google Scholar]
  4. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171:(4):388.
    [Google Scholar]
  5. Hormozi SF, Vasei N, Aminianfar M, Darvishi M, Saeedi AA. Antibiotic resistance in patients suffering from nosocomial infections in Besat Hospital. Eur J Transl Myol. 2018; 28:(3):304-8.
    [Google Scholar]
  6. Heredia-Rodríguez M, Peláez MT, Fierro I, Gómez-Sánchez E, Gómez-Pesquera E, Lorenzo M, et al. Impact of ventilator-associated pneumonia on mortality and epidemiological features of patients with secondary peritonitis. Ann Intensive Care. 2016; 6:(1):34.
    [Google Scholar]
  7. Ali HS, Khan FY, George S, Shaikh N, Al-Ajmi J. Epidemiology and outcome of ventilator-associated pneumonia in a heterogeneous ICU population in Qatar. BioMed Res Int. 2016;2016.
    [Google Scholar]
  8. Wałaszek M, Róz.an′ska A, Wałaszek MZ, Wójkowska-Mach J. Epidemiology of ventilator-associated pneumonia, microbiological diagnostics and the length of antimicrobial treatment in the Polish intensive care units in the years 2013-2015. BMC Infect Dis. 2018; 18:(1):308.
    [Google Scholar]
  9. Inchai J, Pothirat C, Liwsrisakun C, Deesomchok A, Kositsakulchai W, Chalermpanchai N. Ventilator-associated pneumonia: epidemiology and prognostic indicators of 30-day mortality. Jpn J Infect Dis. 2015; 68:(3):181-6.
    [Google Scholar]
  10. Skrupky LP, McConnell K, Dallas J, Kollef MH. A comparison of ventilator-associated pneumonia rates as identified according to the National Healthcare Safety Network and American College of Chest Physicians criteria. Crit Care Med. 2012; 40:(1):281-4.
    [Google Scholar]
  11. Rello J, Afonso E, Lisboa T, Ricart M, Balsera B, Rovira A, et al. A care bundle approach for prevention of ventilator-associated pneumonia. Clin Microbiol Infect. 2013; 19:(4):363-9.
    [Google Scholar]
  12. Resar R, Pronovost P, Haraden C, Simmonds T, Rainey T, Nolan T. Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. Jt Comm J Qual Patient Saf. 2005; 31:(5):243-8.
    [Google Scholar]
  13. Collard HR, Saint S, Matthay MA. Prevention of ventilator-associated pneumonia: an evidence-based systematic review. Ann Intern Med. 2003; 138:(6):494-501.
    [Google Scholar]
  14. Nguile-Makao M, Zahar JR, Français A, Tabah A, Garrouste-Orgeas M, Allaouchiche B, et al. Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models. Intensive Care Med. 2010; 36:(5):781-9.
    [Google Scholar]
  15. Nakos G, Tsangaris H, Liokatis S, Kitsiouli E, Lekka ME. Ventilator-associated pneumonia and atelectasis: evaluation through bronchoalveolar lavage fluid analysis. Intensive Care Med. 2003; 29:(4):555-63.
    [Google Scholar]
  16. Toney BS, Lynch-Smith D. Chronic obstructive pulmonary disease and ventilator-associated pneumonia. Dimens Crit Care Nurs. 2016; 35:(1):16-22.
    [Google Scholar]
  17. de Souza Kock K , Maurici R. Respiratory mechanics, ventilator-associated pneumonia and outcomes in intensive care unit. World J Crit Care Med. 2018; 7:(1):24.
    [Google Scholar]
  18. Bouglé A, Bombled C, Margetis D, Lebreton G, Vidal C, Coroir M, et al. Ventilator-associated pneumonia in patients assisted by veno-arterial extracorporeal membrane oxygenation support: epidemiology and risk factors of treatment failure. PLOS ONE. 2018; 13:(4):e0194976.
    [Google Scholar]
  19. Sabery M, Shiri H, Moradiance V, Taghadosi M, Gilasi H, Khamechian M. The frequency and risk factors for early-onset ventilator-associated pneumonia in intensive care units of Kashan Shahid-Beheshti hospital during 2009-2010. KAUMS J (FEYZ). 2013; 16:(6):560-9.
    [Google Scholar]
  20. Caserta RA, Marra AR, Durão MS, Silva CV, dos Santos OF, de Sousa Neves HS, et al. A program for sustained improvement in preventing ventilator associated pneumonia in an intensive care setting. BMC Infect Dis. 2012; 12:(1):234.
    [Google Scholar]
  21. Papazian L, Thomas P, Garbe L, Guignon I, Thirion X, Charrel J, et al. Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am J Resp Crit Care Med. 1995; 152:(6):1982-91.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2021.21
Loading
/content/journals/10.5339/qmj.2021.21
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): prevention , VAP prevention bundle measures and ventilator-associated pneumonia
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error